Literature DB >> 27475983

Deubiquitinating enzymes in skeletal muscle atrophy-An essential role for USP19.

Simon S Wing1.   

Abstract

The ubiquitin proteasome system is well recognized to be involved in mediating muscle atrophy in response to diverse catabolic conditions. To date, almost all of the genes that have been implicated are ubiquitin ligases. Although ubiquitination is modulated also by deubiquitinating enzymes, the roles of these enzymes in muscle wasting remains largely unexplored. In this article, the potential roles of deubiquitinating enzymes in regulating muscle size are discussed. This is followed by a review of the roles described for USP19, the deubiquitinating enzyme that has been most studied in muscle wasting. This enzyme is upregulated in muscle in many catabolic conditions and its inactivation leads to protection from muscle loss induced by stimuli that are common in many illnesses causing cachexia. It can regulate both protein synthesis and protein degradation as well as myogenesis, thereby modulating the key processes that control muscle mass. Roles for other deubiquitinating enzymes remain possible and to be explored.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; Deubiquitinases; Deubiquitinating enzymes; Muscle wasting; USP14; USP19; USP2; Ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 27475983     DOI: 10.1016/j.biocel.2016.07.028

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

1.  Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength.

Authors:  Brittany C Collins; Eija K Laakkonen; Dawn A Lowe
Journal:  Bone       Date:  2019-03-28       Impact factor: 4.398

Review 2.  Interactions of the super complexes: When mTORC1 meets the proteasome.

Authors:  Olasunkanmi A J Adegoke; Brendan E Beatty; Scot R Kimball; Simon S Wing
Journal:  Int J Biochem Cell Biol       Date:  2019-10-31       Impact factor: 5.085

3.  Ubiquitin-dependent folding of the Wnt signaling coreceptor LRP6.

Authors:  Elsa Perrody; Laurence Abrami; Michal Feldman; Beatrice Kunz; Sylvie Urbé; F Gisou van der Goot
Journal:  Elife       Date:  2016-10-18       Impact factor: 8.140

4.  Interference with Ca2+-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia.

Authors:  Fabrizio Pin; Valerio G Minero; Fabio Penna; Maurizio Muscaritoli; Roberta De Tullio; Francesco M Baccino; Paola Costelli
Journal:  Front Physiol       Date:  2017-04-19       Impact factor: 4.566

5.  Mechanistic Role of Reactive Oxygen Species and Therapeutic Potential of Antioxidants in Denervation- or Fasting-Induced Skeletal Muscle Atrophy.

Authors:  Jiaying Qiu; Qingqing Fang; Tongtong Xu; Changyue Wu; Lai Xu; Lingbin Wang; Xiaoming Yang; Shu Yu; Qi Zhang; Fei Ding; Hualin Sun
Journal:  Front Physiol       Date:  2018-03-14       Impact factor: 4.566

6.  Genomic regions underlying uniformity of yearling weight in Nellore cattle evaluated under different response variables.

Authors:  Laiza Helena de Souza Iung; Herman Arend Mulder; Haroldo Henrique de Rezende Neves; Roberto Carvalheiro
Journal:  BMC Genomics       Date:  2018-08-16       Impact factor: 3.969

Review 7.  USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes.

Authors:  Hiroshi Kitamura; Mayuko Hashimoto
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

8.  Pyrroloquinoline quinone attenuates cachexia-induced muscle atrophy via suppression of reactive oxygen species.

Authors:  Tongtong Xu; Xiaoming Yang; Changyue Wu; Jiaying Qiu; Qingqing Fang; Lingbin Wang; Shu Yu; Hualin Sun
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

9.  Immunohistochemical phenotyping of T cells, granulocytes, and phagocytes in the muscle of cancer patients: association with radiologically defined muscle mass and gene expression.

Authors:  Ana Anoveros-Barrera; Amritpal S Bhullar; Cynthia Stretch; Abha R Dunichand-Hoedl; Karen J B Martins; Aja Rieger; David Bigam; Todd McMullen; Oliver F Bathe; Charles T Putman; Catherine J Field; Vickie E Baracos; Vera C Mazurak
Journal:  Skelet Muscle       Date:  2019-09-14       Impact factor: 4.912

10.  Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.

Authors:  Rujia Miao; Yao Lu; Xue He; Xuelian Liu; Zhiheng Chen; Jiangang Wang
Journal:  J Cell Mol Med       Date:  2020-08-14       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.